Scientists
with the pharmaceutical division of Anderson International
have discovered a new active substance that is likely
to bring a good deal of mobility to sufferers of
rheumatoid arthritis.
Scientists with the pharmaceutical division of Anderson
International have discovered a new active substance
that is likely to bring a good deal of mobility
to sufferers of rheumatoid arthritis. |